| Edit |   |
|---|
| Product Name | Recombinant Staphylococcus aureus (strain MRSA252) Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI |
|---|
| Description | 1-256aa; Full Length. MW: 43.97kD. Purity >90% as determined by SDS-PAGE. Catalyzes the reduction of a carbon-carbon double bond in an enoyl moiety that is covalently linked to an acyl carrier protein (ACP). Involved in the elongation cycle of fatty acid which are used in the lipid metabolism (By similarity). |
|---|
| Size | 0.01 mg (E-Coli), 0.05 mg (E-Coli), 0.1 mg (E-Coli), 0.2 mg (E-Coli), 0.5 mg (E-Coli) |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [NADPH-dependent enoyl-ACP reductase] |
|---|
| Gene, Accession, CAS # | fabI, Accession: WP_000933195.1 |
|---|
| Catalog # | MBS1318662 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Staphylococcus aureus (strain MRSA252) Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI from MYBIOSOURCE INC. |
|---|
| Product Specific References | Structural insights into Staphylococcus aureus enoyl-ACP reductase (FabI), in complex with NADP and triclosan.Priyadarshi A., Kim E.E., Hwang K.Y.Proteins 78:480-486(2010) |
|---|